NLC
Venture studioAmsterdam · Pre-Seed–Seed · 43 people tracked
Find your way into NLC
10,643 people in our graph share verified history with the NLC team — schools, employers, funds. One of them is your warm intro.
Investment thesis
NLC operates as both a venture builder and fund manager focused on healthcare innovation, combining captive deal flow with Europe's largest independent innovation team to identify and derisk early-stage opportunities. Through the SFDR Article 9 compliant NLC Health Impact Fund, it aims to back 80-90 companies, providing early-stage capital while pursuing both financial returns and measurable societal impact. In-house healthcare specialists across digital health, medical technology, and biotech drive investment selection, and the firm emphasizes portfolio diversification across healthcare sectors, geographies, and company stages to manage the inherent risks of early-stage healthcare investing.
Source: firm website, verified Aug 16, 2026.
Team · 43 people
from the firm's website & curated
Founder mafia
2 people who came through NLC went on to found or lead other companies.
What they invest in
from 51 of 74 portfolio companiesMedical Devices ×47Healthtech ×38Biotech ×23Digital Health ×19AI & Machine Learning ×15Deep Tech ×13Hardware ×13Enterprise Software ×2
HQs:Netherlands×15United Kingdom×6United States×4France×2Austria×1Germany×1
Who they back
founder profiles across 22 portfolio companiesFounding team size:solo founder×132 founders×83 founders×1
Where their founders worked beforefrom 12 founders with career history
AMC - Academisch Medisch Centrum ×2
Investments · 74 tracked
founders shown can be your intro path
Neurolieve is a life-science company developing therapeutics for neuropathic and chronic pain, with expertise in neuroscience, clinical pain medicine and drug development.
BiotechDeep TechHealthtechMedical Devices
Co-investorsInnovate UK
Nilocas is developing a medical device with focus on human viability trials.
Deep TechDigital HealthHardwareHealthtechMedical Devices
Aerion Bioscience develops a 6-protein biomarker panel for early detection and staging of lung cancer.
BiotechDigital HealthMedical Devices
Dr. Axel Schumacher(CEO)in
AIDO develops a robotic add-on system, combining hardware and software, that attaches to existing endoscopes to assist endoscopists with complex, non-invasive procedures such as treating colorectal cancer and performing pancreatic biopsies.
HealthtechMedical DevicesRobotics
Charlotte Cave(CEO)in
Allergios develops an in-vitro allergy diagnostic that visualizes allergic responses by analyzing how a patient's blood serum induces basophil degranulation, using a disposable microfluidic chip, an optical reader (GranulEye), and AI-based analysis software.
AI & Machine LearningDigital HealthMedical Devices
Amotio develops a guided bone cement removal system with patient-specific surgical planning and precision instrumentation for orthopaedic revision surgery, targeting arthroplasty and revision surgeons who work with cemented joint implants.
HardwareHealthtechMedical Devices
Iestyn Foster(Founder & CEO)in
Co-investorsDevelopment Bank of Wales
PCaVision is a diagnostic tool that combines multiparametric ultrasound imaging with AI algorithms to detect suspicious areas for prostate cancer, offering urologists a diagnostic pathway that does not require MRI.
AI & Machine LearningDigital HealthMedical Devices
Ansana develops sterilization process management and control solutions for healthcare and pharmaceutical organizations, focusing on patient safety and operational efficiency.
Enterprise SoftwareHealthtechIoTMedical Devices
Dominique Surinx(CEO & Co-Founder)in
Audaxis Medical develops biocompatible pelvic health implants using next-generation biomaterials designed to integrate with the body and replace legacy materials.
BiotechFemTechHealthtechMedical Devices
BoardChristopher Chapple(Co-Inventor, Senior Medical Advisor)Sheila MacNeil(Co-Inventor, Senior Medical Advisor)
Axial Orthopaedics is a medtech company in orthopedic healthcare, with leadership experienced in strategic exits.
BiotechDeep TechHealthtechMedical Devices
Craig Corrance(CEO)
Concord develops equipment and protocols for physiological-based cord clamping, enabling neonatal caregivers to provide care with the umbilical cord intact until a newborn is fully stable and breathing independently.
HardwareHealthtechLongevityMedical DevicesLeiden, NL
Arjan te Pas(Professor)Stuart Hooper(Professor)
Crainio develops a non-invasive brain monitoring device that uses an optical sensor placed on the forehead to detect rising intracranial pressure and intracranial hypertension.
HardwareHealthtechMedical Devices
Co-investorsOxford Investment Opportunity Network (OION)
Developing small molecule antagonists.
Orally available small-molecule therapy targeting the RAGE/DIAPH1 pathway for metabolic and inflammatory conditions.
Co-investors4impact capitalAct Venture CapitalACT Venture CapitalAmadeus Capital SAAngel Physicians FundAnkur Capital+65 more
Early-stage drug delivery company.
Exolvo Biosciences develops drug delivery technology.
BiotechDeep TechMedical Devices
Brian Longstreet(Co-founder & CEO)
Scanner providing immediate imaging of biopsy and surgical specimens to distinguish healthy tissue from tumors in real time.
Foveo Fertility develops solutions for fertility treatment.
Digital HealthFemTechHealthtechMedical Devices
Eva van Rooijen(CEO & Co-Founder)in
Garland Surgical develops the TriActiv Hip (formerly MaltaHip), a total hip replacement implant using a patented tri-axial design intended to improve mobility, stability, and durability while reducing revision surgeries.
HardwareHealthtechMedical DevicesWorcester, GB
Simon Mifsud(Founder & Group Chief Executive Officer)inJohn Shapland(Chief Technology Officer)in
Haermonics is a clinical-stage medtech company that developed the Haermonics Pure System, a continuous postoperative pericardial flush therapy designed to keep chest tubes clear and prevent bleeding-related complications after open-heart cardiac surgery.
HardwareHealthtechMedical DevicesEindhoven, NL
David R. Koolbergen(Inventor of the therapy; Congenital Cardiothoracic Surgeon)in
Co-investorsBOM
HapticHeart Solutions builds a device-agnostic system that converts biophysical and physiological signals from cardiac catheterization, electrophysiology, and robotic interventions into haptic feedback delivered to operators through a wearable interface and handle.
BiotechHardwareHealthtechMedical Devices
Hemeo develops AI-based clinical decision support software that consolidates data from multiple sources to predict coagulation risks and personalize the prevention and treatment of bleeding and thrombosis.
AI & Machine LearningDigital HealthHealthtechAmsterdam, NL
Rene van den Ham(Founder)in
Handheld induction device that heats implants to eliminate bacteria causing prosthetic joint infections.
Implant Preservation Devices develops orthopedic implant devices for medical and surgical applications.
BiotechHealthtechMedical DevicesAmsterdam, NL
Richard van de Wateringen(CEO)
Kaminari Medical develops intravascular imaging technology for cardiovascular interventions, using photoacoustic and optical innovations.
BiotechDeep TechDigital HealthHealthtechMedical DevicesRotterdam, NL
Prof. Dr. Gijs van Soest(Inventor)Prof. Dr. Ton van der Steen(Inventor)Verya Daeichin(CTO/Inventor)in
Lamina Therapeutics develops Lamina.One, a combined advanced therapy medicinal product for bone and cartilage regeneration that pairs a biodegradable polymeric membrane with hydroxyapatite and an autologous mesenchymal stem cell hydrogel to treat knee osteoarthritis and orthopaedic, maxillofacial, and periodontal conditions.
BiotechHealthtechMedical DevicesStrasbourg, FR
Nadia Benkirane-Jessel(Founder)Stephan Lemmens(CEO)in
LarynxLock is a single-use medical device that prevents airway leakage in supraglottal airway devices, applied externally to patient skin for use in operating rooms, pre-hospital settings, and procedural sedation.
CleantechHardwareHealthtechMedical DevicesMaastricht, NL
Loresa develops minimally invasive surgical devices for resource-limited settings, with a focus on eliminating the need for insufflation in abdominal surgery.
Deep TechHardwareHealthtechImpact & Social GoodMedical Devices
Dr. Deborah MaufiWillem Fontijn
BoardEllis Aune
LUMABS BV develops RAPPID, a rapid, one-step immunoassay technology that enables sensitive antibody detection from minimal blood samples for diagnostics and therapeutic monitoring.
AI & Machine LearningBiotechMedical Devices
MindAffect develops brain-computer interface technology that measures automatic neural responses to auditory and visual stimuli using EEG, enabling objective hearing and vision assessment for patients who cannot respond behaviorally (young children, individuals with disabilities, older adults).
AI & Machine LearningDeep TechHealthtechMedical Devices
Gene therapy delivering microRNA-335 via AAV9 viral vector for drug-resistant epilepsy.
Methylation-based test for personalized melanoma malignancy measurement and prognosis.
MLA Diagnostics develops a melanoma diagnostic test based on DNA methylation biomarkers to improve patient risk stratification and treatment decisions.
BiotechDigital HealthMedical DevicesMaastricht, NL
Manon van Engeland(Inventor and Co-founder)Egbert Smit(CEO)
NC Biomatrix develops biologic therapies targeting musculoskeletal degeneration, with a lead product (VitaDisc) addressing intervertebral disc degeneration and chronic lower back pain, and ongoing research into osteoarthritis treatments for synovial joints.
BiotechHealthtechMedical Devices
Developing small molecule therapies for neurodegenerative diseases.
Nicolab builds StrokeViewer, an AI-powered, cloud-based platform for acute care teams that speeds up stroke triage by giving physicians fast access to DICOM imaging, patient timelines, and secure messaging across hospitals.
AI & Machine LearningDigital HealthMedical Devices
Merel Boers(Co-Founder)in
Co-investorsPerennial Partners
PCaVision combines multiparametric ultrasound imaging with AI algorithms to detect suspicious areas for prostate cancer, offering a diagnostic pathway for urologists that avoids the need for MRI.
AI & Machine LearningDigital HealthMedical Devices
PEP Health uses AI to analyze millions of unsolicited patient comments and turn them into benchmarkable, predictive insights on care quality, patient experience, and reputation.
AI & Machine LearningDigital HealthHealthtech
Blood test using an extracellular vesicle protein signature to identify stable angina patients early.
Persuasive develops a platform technology for high-throughput analysis of extracellular vesicles (EVs) and is building a blood-based diagnostic test using an EV protein biomarker signature to identify chronic coronary syndrome in primary-care patients presenting with chest pain.
BiotechDigital HealthHealthtech
A company that has completed first-in-human clinical trials for its products and is pursuing regulatory approvals for worldwide commercialization.
BiotechHealthtechMedical DevicesNew Materials
Profionics develops host-response biomarker technology for rapid detection and diagnosis of sepsis.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCardiff, GB
Professor Peter Ghazal(Co-founder)Darren Fergus(Co-founder & CEO)inDr Daniel White(CTO)
BoardGina Melchner von Dydiowa(Venture Partner)
Provasctec develops a cell therapy combining mesenchymal stem cells with a biodegradable delivery device to create new vascular pathways, with a lead program targeting critical limb ischemia in peripheral artery disease patients.
BiotechHealthtechMedical Devices
Holger Muller(CEO & Co-Founder)inNoel Caplice(CSO & Co-Founder)in
Respiosa develops a minimally invasive surgical implant to treat obstructive sleep apnea by preventing tongue collapse during sleep, targeting patients for whom current treatments like CPAP are ineffective or poorly tolerated.
HealthtechMedical Devices
Co-investorsDeepbridge Capital
RetinaCheck was a Sino-Dutch research project and TU/e startup that developed computer-aided diagnosis software using geometric methods and deep learning to automatically analyze retinal fundus images for early detection of diabetic retinopathy and other eye diseases.
AI & Machine LearningDigital HealthMedical DevicesEindhoven, NL
Revadix develops first-in-class small molecule therapies targeting the EPAC1 signalling pathway to treat atrial fibrillation, addressing the underlying disease mechanism rather than symptoms.
BiotechDeep TechMedical DevicesToulouse, FR
Frank Lezoualc'h(Scientific Founder / Research Director at Inserm)
Rheumasense develops clinical diagnostic testing technology aimed at transforming the management and care of rheumatoid arthritis.
AI & Machine LearningDigital HealthMedical Devices
John M. Davis III(Co-Inventor, Professor of Medicine & Chair, Division of Rheumatology, Mayo Clinic)inJen Skeen(CEO)in
Sanmirna Therapeutics develops microRNA-targeted therapeutics for cancer treatment, with its lead candidate Miristen™ currently in Phase I clinical trials for acute myeloid leukemia.
AI & Machine LearningBiotechHealthtechMedical DevicesAmsterdam, US
Apheresis filtering technology to remove pathogens from blood for sepsis treatment; developed by Sanquin.
Scinvivo develops Lumante, a catheter-based optical coherence tomography (OCT) imaging platform for real-time, minimally invasive visualization and local staging of bladder cancer during cystoscopy.
Deep TechHealthtechMedical DevicesEindhoven, NL
Marijn van Os(Co-founder & CEO)inDiederik van Lierop(Co-founder, Software/Hardware Developer)inMaaike de Jong(CMO (Chief Medical Officer))inCamile van der Heijden(CTO)inLiesbeth Geerts(CCO)inMaarten Haast(CFO)in
Enzymatic hydrogel debrider that selectively breaks down necrotic tissue for burn and chronic wound care.
SERDA therapeutics is developing a prescription enzyme-based product for therapeutic debridement, using a proteolytic enzyme to selectively digest and remove necrotic tissue and eschar from wounds.
BiotechMedical Devices
Implant-free radiofrequency device to close patent foramen ovale (PFO) in stroke-risk patients.
StarTric develops a minimally invasive transcatheter device for repairing the tricuspid heart valve, designed to replicate the open-heart Clover surgical technique for treating tricuspid regurgitation.
HardwareHealthtechMedical Devices
Michele De Bonis(Founder)Ottavio Alfieri(Founder)
Co-investorsGrowth Capital
TimeLab builds scientifically validated operational decision support software, using AI-driven systems and near-future state assessments to improve dispatch and fleet deployment for emergency services.
AI & Machine LearningDeep TechEnterprise SoftwareGovTechHealthtechAmsterdam, EU
Side-viewing ultrasound probe for real-time tool-in-lesion confirmation during endobronchial lung cancer biopsies.
Venous Stent develops ALTA®, a modular stent designed to treat deep venous disease in the iliac and femoral veins.
HardwareHealthtechMedical Devices
BoardCees Wittens(Venous surgeon (design expert))
Wavefront develops quantitative 3D cell imaging technology for biomedical researchers to accelerate discoveries in cell science and healthcare applications.
AI & Machine LearningBiotechDeep TechMedical Devices
Manuel Martinez(Inventor and Co-founder)inWilson Gomes(CEO and Co-founder)in
Gene therapy using tRNA supplementation to treat Charcot Marie Tooth disease type 2D.
Portfolio news
latest coverage across their companiesNicolab · afr.com · Jul 29, 2026
Frequently asked questions
- How many investments has NLC made?
- NLC has 74 tracked investments.
- What stage does NLC invest at?
- NLC invests at the Pre-Seed, Seed stages.
- What sectors does NLC focus on?
- NLC focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Longevity, Medical Devices.
- Where is NLC located?
- NLC is headquartered in Amsterdam, NL.
- Who does NLC co-invest with?
- NLC most often shares deals with BOM, Deepbridge Capital, Growth Capital, among 5 tracked co-investors.
Media · Podcasts & interviews
featuring the teamBert-Arjan Millenaar on NLC Health | Building 85+ HealthTech Startups & Crowdfunding Innovation
Odelle Technology · Bert-Arjan Millenaar
#115: Founder/CEO NLC Bert-Arjan Millenaar: How can we make more medical innovations profitable?
De Nieuwe Wereld · Bert-Arjan Millenaar
Images
Similar investors
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
The Dementia Discovery Fund (DDF), managed by SV Health Investors, is a family of specialized venture capital funds investing exclusively in companies developing or enabling novel therapeutics for dementia, including Alzheimer's Disease.